The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...

Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, ...

FDA's Orange Book: Iterum has submitted patent information for four U.S. patents for ORLYNVAH TM that will be listed in FDA's Orange Book: Approved Drug Products with Therapeutic Equivalence ...

Research and development (R&D) expenses for the third quarter 2024 were $3.1 million compared to $14.9 million for the same period in 2023. The decrease for the three-month period was primarily due to ...

Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that ...

Adapted from the 2014 biography titled ‘The Short and Tragic Life of Robert Peace’ written by Jeff Hobbs, ‘Rob Peace’ is a ...

In this edition of Endnotes, we take a look at Stephen G. Bloom's The Brazil Chronicles (Univ. of Missouri, Nov.), which ...

Good afternoon, ladies and gentlemen, and welcome, everyone, to the Maravai LifeSciences Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

Sandoz Inc.’s proposed generic version of Inlyta infringes a patent for the kidney-cancer chemotherapy treatment, Pfizer Inc.

What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...

Under Donald Trump and Joe Biden alike, the US has been determined to “reshore” chipmaking. Now money and colossal ...